Literature DB >> 18186617

Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.

Amy E Schmidt1, Mao-fu Sun, Taketoshi Ogawa, S Paul Bajaj, David Gailani.   

Abstract

In serine proteases, Gly193 (chymotrypsin numbering) is conserved with rare exception. Mutants of blood coagulation proteases have been reported with Glu, Ala, Arg or Val substitutions for Gly193. To further understand the role of Gly193 in protease activity, we replaced it with Ala or Val in coagulation factor XIa (FXIa). For comparison to the reported FXIa Glu193 mutant, we prepared FXIa with Asp (short side chain) or Lys (opposite charge) substitutions. Binding of p-aminobenzamidine (pAB) and diisopropylfluorphosphate (DFP) were impaired 1.6-36-fold and 35-478-fold, respectively, indicating distortion of, or altered accessibility to, the S1 and oxyanion-binding sites. Val or Asp substitutions caused the most impairment. Salt bridge formation between the amino terminus of the mature protease moiety at Ile16 and Asp194, essential for catalysis, was impaired 1.4-4-fold. Mutations reduced catalytic efficiency of tripeptide substrate hydrolysis 6-280-fold, with Val or Asp causing the most impairment. Further studies were directed toward macromolecular interactions with the FXIa mutants. kcat for factor IX activation was reduced 8-fold for Ala and 400-1100-fold for other mutants, while binding of the inhibitors antithrombin and amyloid beta-precursor protein Kunitz domain (APPI) was impaired 13-2300-fold and 22-27000-fold, respectively. The data indicate that beta-branching of the side chain of residue 193 is deleterious for interactions with pAB, DFP and amidolytic substrates, situations where no S2'-P2' interactions are involved. When an S2'-P2' interaction is involved (factor IX, antithrombin, APPI), beta-branching and increased side chain length are detrimental. Molecular models indicate that the mutants have impaired S2' binding sites and that beta-branching causes steric conflicts with the FXIa 140-loop, which could perturb the local tertiary structure of the protease domain. In conclusion, enzyme activity is impaired in FXIa when Gly193 is replaced by a non-Gly residue, and residues with side chains that branch at the beta-carbon have the greatest effect on catalysis and binding of substrates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18186617      PMCID: PMC2885443          DOI: 10.1021/bi701594j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.

Authors:  M F Sun; M Zhao; D Gailani
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.

Authors:  S Paul Bajaj; Amy E Schmidt; Sayeh Agah; Madhu S Bajaj; Kaillathe Padmanabhan
Journal:  J Biol Chem       Date:  2006-06-06       Impact factor: 5.157

3.  Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.

Authors:  Taketoshi Ogawa; Ingrid M Verhamme; Mao-Fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2005-04-13       Impact factor: 5.157

4.  Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases.

Authors:  Kevin M Bobofchak; Agustin O Pineda; F Scott Mathews; Enrico Di Cera
Journal:  J Biol Chem       Date:  2005-05-12       Impact factor: 5.157

5.  Crystal structure of the factor XI zymogen reveals a pathway for transactivation.

Authors:  Evangelos Papagrigoriou; Paul A McEwan; Peter N Walsh; Jonas Emsley
Journal:  Nat Struct Mol Biol       Date:  2006-05-14       Impact factor: 15.369

Review 6.  Blood coagulation.

Authors:  S Butenas; K G Mann
Journal:  Biochemistry (Mosc)       Date:  2002-01       Impact factor: 2.487

7.  Crystal structure reveals basis for the inhibitor resistance of human brain trypsin.

Authors:  Gergely Katona; Gunnar I Berglund; Janos Hajdu; László Gráf; László Szilágyi
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

8.  Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2.

Authors:  Duraiswamy Navaneetham; Lei Jin; Pramod Pandey; James E Strickler; Robert E Babine; Sherin S Abdel-Meguid; Peter N Walsh
Journal:  J Biol Chem       Date:  2005-08-06       Impact factor: 5.157

9.  Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.

Authors:  Rodney M Camire
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

10.  Thermodynamic analysis reveals structural rearrangement during the acylation step in human trypsin 4 on 4-methylumbelliferyl 4-guanidinobenzoate substrate analogue.

Authors:  Júlia Tóth; Linda Gombos; Zoltán Simon; Péter Medveczky; László Szilágyi; László Gráf; András Málnási-Csizmadia
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

View more
  4 in total

1.  Reengineering of the feedback-inhibition enzyme N-acetyl-L-glutamate kinase to enhance L-arginine production in Corynebacterium crenatum.

Authors:  Jingjing Zhang; Meijuan Xu; Xiaoxun Ge; Xian Zhang; Taowei Yang; Zhenghong Xu; Zhiming Rao
Journal:  J Ind Microbiol Biotechnol       Date:  2016-12-22       Impact factor: 3.346

Review 2.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

3.  A receptor dependent-4D QSAR approach to predict the activity of mutated enzymes.

Authors:  R Pravin Kumar; Naveen Kulkarni
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

4.  Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10.

Authors:  Mekdes Debela; Viktor Magdolen; Wolfram Bode; Hans Brandstetter; Peter Goettig
Journal:  Biol Chem       Date:  2016-12-01       Impact factor: 3.915

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.